Pretreatment with the SIRT1 activator SRT1720 mitigated the renal proximal tubule dropout in CIN, detected by renal HE scores, an effect that was blocked by the SIRT1 antagonist EX527 (Figure 4(a)). Here, SIRT1 is linked to hereditary elliptocytosis.